Buy Jubilant Organosys; target 455: Emkay Global Financial Services

Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services in an interview with ET Now talks about Jubilant Organosys.

What are your buzzing bets for today?

We have a buy report on Jubilant Organosys with the target of 455. I want to draw attention back again to this stock. We have seen a very strong operational performance here. They have been speaking of demerging their non-core business. So that will help them get their synergies better.

In a challenging environment where lot of CRAM companies, CRAM based models have not done well, the stock has. So we have a buy recommendation on the stock with the target of 455, which discounts its FY12 estimated EPS of about Rs 42 by about 11 times.